Beyond CAR-T: Re-engineering Cells into Life-saving Therapies - Curetalks

Beyond CAR-T: Re-engineering Cells into Life-saving Therapies

Our cells have the innate ability to protect us. The idea of using cells as medicine emerged with bone marrow transplants, and then CAR-T therapy for blood cancers. Now, scientists are beginning to engineer much more complex living therapeutics by tapping into the capabilities of living cells to treat a growing list of diseases.

The power of cellular therapy is being explored to halt and reverse disease, restore damaged organs, and, ultimately, cure many life-threatening conditions. Important advances in the understanding of disease biology and major innovations in gene editing, protein engineering and cell culture technology have created a highly fertile scientific environment in which cell therapy research is flourishing. 

We are talking to Dr. Lawrence Fong, Efim Guzik Distinguished Professor in Cancer Biology and Cancer Immunotherapy Program lead at UCSF about treatments and disease area focus, advantages of harnessing the power of cellular therapy, challenges faced, new initiatives and global awareness of these programs. 

Add to Calendar

CureTalks is an online Talk featuring a leading expert in conversation with a panel and the audience. The audience can ask questions from the panelists LIVE on the talk by dial-ing in. To hear the talk via phone or on-line, please add your email on the left; we will send you Live Talk access details. You can also write your questions in the Comments/Questions section below and your question maybe selected to be featured on the talk.

Submit a question for the panelists or leave a comment below.

Your email address will not be published. Required fields are marked *